- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00966108
SENSIMED Triggerfish Discomfort During IOP Monitoring (09/02)
February 3, 2010 updated by: Sensimed AG
Evaluation of SENSIMED Triggerfish for 24 Hour IOP Monitoring in Healthy Subjects and Glaucoma Patients
Evaluation of the wearing discomfort (safety and tolerability) involved during IOP monitoring with the SENISMED Triggerfish, a sensor embedded in a telemetric contact lens
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rheinland-Pfalz
-
Mainz, Rheinland-Pfalz, Germany, 55131
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Healthy subjects and glaucoma patients
Description
Inclusion Criteria:
- Patient is able to comply with the study procedure
- Patient is 18-80 years old
- Healthy subject or glaucoma patient
- Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out
- Cylinder refraction of no more than +/- 2 diopters in the study eye
- Visual acuity of 20/80 or better in the study eye
- Ability of subject to understand the character and individual consequences of the study
- For women with childbearing potential, adequate contraception
Exclusion Criteria:
- Subjects wearing contact lenses within the last two years
- Subjects with contraindications for wearing contact lenses
- History of refractive surgery
- History of intraocular surgery in the last three months
- Severe dry eye syndrome
- Keratoconus or other corneal abnormalities
- Conjunctival or intraocular inflammation
- Pregnancy and lactation
- Simultaneous participation in other clinical trials
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy subjects
|
Ocular Telemetry Sensor for IOP monitoring
|
|
Glaucoma patients
|
Ocular Telemetry Sensor for IOP monitoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ocular discomfort on a visual analogue scale
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Norbert Pfeiffer, Prof. Dr. med., Universitätsmedizin Mainz
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
January 1, 2010
Study Completion (Actual)
January 1, 2010
Study Registration Dates
First Submitted
August 24, 2009
First Submitted That Met QC Criteria
August 24, 2009
First Posted (Estimate)
August 26, 2009
Study Record Updates
Last Update Posted (Estimate)
February 4, 2010
Last Update Submitted That Met QC Criteria
February 3, 2010
Last Verified
February 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09/02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Safety and Tolerability of SENSIMED Triggerfish in Glaucoma Patients
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingTo Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
-
National Medical Research Radiological Centre of...Active, not recruitingAssess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid TumorRussia
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHealthy Volunteers | Pharmacokinetics of Isavuconazole | Safety and Tolerability in ElderlyUnited States
-
AB BiotekFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauCompletedSafety and Tolerability in Healthy VolunteersSpain
-
Veralox TherapeuticsCompletedSafety and Tolerability in Healthy VolunteersUnited States
-
Bioniz TherapeuticsCelerionCompletedSafety and Tolerability in Healthy SubjectsUnited States
-
Bactolife A/SAtlantia Food Clinical TrialsRecruiting
-
Annexon, Inc.TerminatedSafety and Tolerability in Healthy VolunteersAustralia
-
Neuraly, Inc.CompletedSafety and Tolerability in Healthy VolunteersUnited States
-
Yunnan Zhongke Longjin Biotechnology Co.,Ltd.CompletedEvaluate the Safety and Tolerability of ZKLJ02 Injection in Healthy Chinese Research ParticipantsChina
Clinical Trials on SENSIMED Triggerfish
-
Sensimed AGUniversity Hospital, GenevaTerminated
-
Sensimed AGPrivate practicioner, Dr Sunaric Mégevand; Orasis, AugenZentrum PajicTerminatedPigmentary Dispersion Syndrome | Pigmentary Glaucoma PatientsSwitzerland
-
Sensimed AGCompleted
-
Sensimed AGTerminatedPrimary Open-angle Glaucoma (POAG) PatientUnited States
-
Sensimed AGCompletedSleep Apnea, Obstructive | Primary Open-angle GlaucomaUnited States
-
Sensimed AGClinique MonchoisiTerminatedPrimary Open Angle GlaucomaSwitzerland
-
Sensimed AGCompleted
-
University Hospital, BordeauxCompletedOpen Angle Glaucoma With a Progressive Visual FieldFrance